Dimitri Breems

4.3k citations

44 papers · 2.2k indexed · 1 hit paper · h-index 18

Hematology top 0.5%
- Acute Myeloid Leukemia Research 24
- Hematopoietic Stem Cell Transplantation 16
- Chronic Myeloid Leukemia Treatments 5
- Multiple Myeloma Research and Treatments 4
Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Mesenchymal stem cell research 3
Public Health, Environmental and Occupational Health top 5%
- Acute Lymphoblastic Leukemia research 7
Oncology top 10%
Immunology top 10%
Molecular Biology
- Histone Deacetylase Inhibitors Research 5

Co-authors: Bob Löwenberg Wim L.J. van Putten Georgine E. de Greef R. E. Ploemacher Gert J. Ossenkoppele H. Berna Beverloo S Neben Edo Vellenga
Cited by: Hematology Genetics Public Health, Environmental and Occupational Health
Journals: Blood (12 papers)British Journal of Haematology (5 papers)Journal of Clinical Oncology (4 papers)
Partner nations: Netherlands Belgium Switzerland

In The Last Decade

Dimitri Breems

44 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Dimitri Breems

Since Specialization

Citations

This map shows the geographic impact of Dimitri Breems's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Breems with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Breems more than expected).

Fields of papers citing papers by Dimitri Breems

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Breems. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Breems. The network helps show where Dimitri Breems may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dimitri Breems, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dimitri Breems Line = papers co-authored together Dimitri Breems links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial Blood Cancer Journal ·Leonard Mukhammidjanovich Sabirov,María Eugenia Tablar,Kazem Nasserinejad,Joost van Rosmalen,Thomas Pabst,Johan Maertens,Dimitri Breems,Markus G. Manz,Jacqueline Cloos,Gert J. Ossenkoppele,Yngvar Fløisand,Patrycja Gradowska,Bob Löwenberg,Gerwin Huls,Douwe Postmus,Francesco Pignatti,Jan J. Cornelissen	2024	3
2	Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab Viruses ·Мякутина Ирина Викторовна,Michael S. Stratton,My Kieu Ha,范韩生,Yang Min-Tzu,Dimitri Breems,Pieter Meysman,Kris Laukens,Walter Verstrepen,María José Altamar-García,Benson Ogunjimi,Kevin K. Ariën,Reinout Naesens	2022	7
3	Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndromebreakdown → Blood ·Tim Grob,Adil S. A. Al Hinai,Mathijs A. Sanders,François G. Kavelaars,Melissa Rijken,Patrycja Gradowska,Bart J. Biemond,Dimitri Breems,Johan Maertens,Marinus van Marwijk Kooy,Thomas Pabst,Okke de Weerdt,Gert J. Ossenkoppele,Arjan A. van de Loosdrecht,Gerwin Huls,Jan J. Cornelissen,H. Berna Beverloo,Bob Löwenberg,Mojca Jongen‐Lavrencic,Peter J.M. Valk	2022	159
4	A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes Annals of Hematology ·Mikkael A. Sekeres,Michael Schuster,Magalie Joris,Jürgen Krauter,Johan Maertens,Dimitri Breems,Emmanuel Gyan,Tibor Kovacsovics,Amit Verma,Paresh Vyas,Eunice S. Wang,Keith A. Ching,Thomas O’Brien,Corrado Gallo Stampino,Weidong Wendy,Arthur J. Kudla,Geoffrey Chan,Amer M. Zeidan	2022	11
5	Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation Blood Advances ·KEMPO TSUKAMOTO,Yvette van Norden,Michel van Gelder,Dimitri Breems,Johan Maertens,Mojca Jongen‐Lavrencic,Annoek E. C. Broers,Eric Braakman,Tim Grob,Wendelien Zeijlemaker,Gert J. Ossenkoppele,Ellen Meijer,Jan J. Cornelissen	2020	22
6	Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients Blood ·Gerwin Huls,Dana Chiţu,Violaine Havelange,Mojca Jongen‐Lavrencic,Arjan A. van de Loosdrecht,Bart J. Biemond,Harm Sinnige,Gianluca Giove,Carlos Graux,Ms. Lena Melhem,Okke de Weerdt,Dimitri Breems,Saskia K. Klein,Jürgen Kuball,Dries Deeren,Wim Terpstra,Marie‐Christiane Vekemans,Gert J. Ossenkoppele,Edo Vellenga,Bob Löwenberg,(unknown)	2019	119
7	Clinical implications of measurable residual disease in AML: Review of current evidence Critical Reviews in Oncology/Hematology ·Ine Moors,Karl Vandepoele,Jan Philippé,Dries Deeren,Dominik Selleslag,Dimitri Breems,Nicole Straetmans,Tessa Kerre,Barbara Denys	2018	16
8	Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15) Blood ·Nada Khoury,Dana Chiţu,Violaine Havelange,Mojca Jongen‐Lavrencic,Mandetta Clementino,Bart J. Biemond,dk,Gianluca Giove,Carlos Graux,Nguyen Huy Thao,Okke de Weerdt,Dimitri Breems,Saskia K. Klein,Jürgen Kuball,Gert J. Ossenkoppele,Bob Löwenberg,Edo Vellenga	2017	5
9	A phase 2, randomized, double‐blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low‐ or intermediate‐1–risk myelodysplastic syndrome American Journal of Hematology ·Guillermo Garcia‐Manero,Gary Gartenberg,David P. Steensma,Martin R. Schipperus,Dimitri Breems,Raquel de Paz,David Valcárcel,Qingquan Ren,Manjula Reddy,Rami S. Komrokji	2014	22
10	MANAGEMENT OF MYELODYSPLASTIC SYNDROMES IN ADULTS: GUIDELINES FROM THE BELGIAN HAEMATOLOGICAL SOCIETY1 The responsibility of the content of these guidelines lies with the Belgian Haematological Society. The editorial board of the Acta Clinica Belgica is not responsible for eventual weaknesses or lack of evidence of the published document Acta Clinica Belgica* ·Stef Meers,Dimitri Breems,L. WALLINGFORD,Michel Delforge,Carlos Graux,Christophe Ravoet,Dominik Selleslag,Lucien Noens	2013	2
11	A phase I first‐in‐human study with tefinostat – a monocyte/macrophage targeted histone deacetylase inhibitor – in patients with advanced haematological malignancies British Journal of Haematology ·Gert J. Ossenkoppele,Bob Löwenberg,Pierre Zachée,Norbert Vey,Dimitri Breems,Arjan A. van de Loosdrecht,Alan H. Davidson,Graham Wells,Lindsey Needham,Lindsay J. Bawden,Martin Toal,Leon Hooftman,Phillip Debnam	2013	34
12	The impact of abn(17p) and monosomy −5/del(5q) on the prognostic value of the monosomal karyotype in acute myeloid leukemia Blood ·Dimitri Breems,Wim L.J. van Putten,Bob Löwenberg	2013	7
13	Acute Myeloid Leukemia and the Position of Autologous Stem Cell Transplantation Seminars in Hematology ·Dimitri Breems,Bob Löwenberg	2007	34
14	Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial British Journal of Haematology ·Bronno van der Holt,Dimitri Breems,H. Berna Beverloo,Eva van den Berg,Alan K. Burnett,Pieter Sonneveld,Bob Löwenberg	2006	47
15	Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia British Journal of Haematology ·Dimitri Breems,Bob Löwenberg	2005	18
16	Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch–Belgian Haemato‐Oncology Co‐operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial British Journal of Haematology ·Dimitri Breems,Marc Boogaerts,A. W. Dekker,Wim L.J. van Putten,Pieter Sonneveld,Peter C. Huijgens,J. van der Lelie,Edo Vellenga,Aloïs Gratwohl,Gregor Verhoef,Leo F. Verdonck,Bob Löwenberg	2004	57
17	Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion European Journal Of Haematology ·Dimitri Breems,Pieter Sonneveld,Rob A. de Man,Frank W.G. Leebeek	2004	8
18	The role of advanced atherosclerosis in idiopathic retroperitoneal fibrosis Analysis of nine cases The Netherlands Journal of Medicine ·Dimitri Breems	2000	13
19	Frequency Analysis of Multidrug Resistance -1 Gene Transfer into Human Primitive Hematopoietic Progenitor Cells Using the Cobblestone Area-Forming Cell Assay and Detection of Vector-Mediated P-Glycoprotein Expression by Rhodamine-123 Human Gene Therapy ·Stefan Früehauf,Dimitri Breems,Shoshan Knaän‐Shanzer,Iván L. Sempere Massa,Rainer Haas,Bob Löwenberg,Kees Nooter,R. E. Ploemacher,Dinko Valerio,茂雄荒木	1996	40
20	Characterization of the translocation breakpoint sequences of two DEK‐CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET‐CAN fusion gene found in a case of acute undifferentiated leukemia Genes Chromosomes and Cancer ·Marieke von Lindern,Dimitri Breems,Sjozèf van Baal,Henk J Adriaansen,Gerard C. Grosveld	1992	87

About Dimitri Breems

Dimitri Breems is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Virology, having authored 44 papers that have together received 2.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Hematopoietic Stem Cell Transplantation (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Mesenchymal stem cell research (3 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (570 citations), Public Health, Environmental and Occupational Health (497 citations), Oncology (363 citations) and Immunology (225 citations). Dimitri Breems has collaborated with scholars based in Netherlands, Belgium and Switzerland. Frequent co-authors include Bob Löwenberg, Wim L.J. van Putten, Georgine E. de Greef, R. E. Ploemacher, Gert J. Ossenkoppele, H. Berna Beverloo, S Neben, Edo Vellenga, Leo F. Verdonck and Clemens Mellink. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, HemaSphere and Human Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact